Megumi Murakami

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Molecular Dynamics Simulations

Multidrug Resistant

Structural Basis

Tyrosine Kinase

Top Venues

International journal of molecular sciences

Proceedings of the National Academy of Sciences of the United States of America

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Chung-Pu Wu, Cheng-Yu Hung, Megumi Murakami, Yu-Shan Wu, Yi-Hsuan Chu, Yang-Hui Huang, Jau-Song Yu, Suresh V Ambudkar
ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in Cancer Cells. International journal of molecular sciences 25 (10) (2024)
Chung-Pu Wu, Cheng-Yu Hung, Megumi Murakami, Yu-Shan Wu, Yi-Hsuan Chu, Yang-Hui Huang, Jau-Song Yu, Suresh V Ambudkar
ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in Cancer Cells. International journal of molecular sciences 25 (10) (2024)
Chung-Pu Wu, Cheng-Yu Hung, Megumi Murakami, Yu-Shan Wu, Yi-Hsuan Chu, Yang-Hui Huang, Jau-Song Yu, Suresh V Ambudkar
ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in Cancer Cells. International journal of molecular sciences 25 (10) (2024)
Chao-Yun Cai, Qiu-Xu Teng, Megumi Murakami, Suresh V Ambudkar, Zhe-Sheng Chen, Vijaya L Korlipara
Design, Synthesis and Biological Evaluation of Quinazolinamine Derivatives as Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors with Improved Metabolic Stability. Biomolecules 13 (2) (2023)
Chung-Pu Wu, Cheng-Yu Hung, Ya-Ju Hsieh, Megumi Murakami, Yang-Hui Huang, Tsung-Yao Su, Tai-Ho Hung, Jau-Song Yu, Yu-Shan Wu, Suresh V Ambudkar
ABCB1 and ABCG2 Overexpression Mediates Resistance to the Phosphatidylinositol 3-Kinase Inhibitor HS-173 in Cancer Cell Lines. Cells 12 (7) (2023)
Chung-Pu Wu, Yen-Ching Li, Megumi Murakami, Sung-Han Hsiao, Yun-Chieh Lee, Yang-Hui Huang, Yu-Tzu Chang, Tai-Ho Hung, Yu-Shan Wu, Suresh V Ambudkar
Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells. International journal of molecular sciences 24 (18) (2023)
Chao-Yun Cai, Qiu-Xu Teng, Megumi Murakami, Suresh V Ambudkar, Zhe-Sheng Chen, Vijaya L Korlipara
Design, Synthesis and Biological Evaluation of Quinazolinamine Derivatives as Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors with Improved Metabolic Stability. Biomolecules 13 (2) (2023)
Chao-Yun Cai, Qiu-Xu Teng, Megumi Murakami, Suresh V Ambudkar, Zhe-Sheng Chen, Vijaya L Korlipara
Design, Synthesis and Biological Evaluation of Quinazolinamine Derivatives as Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors with Improved Metabolic Stability. Biomolecules 13 (2) (2023)
Chung-Pu Wu, Megumi Murakami, Yen-Ching Li, Yang-Hui Huang, Yu-Tzu Chang, Tai-Ho Hung, Yu-Shan Wu, Suresh V Ambudkar
Imperatorin Restores Chemosensitivity of Multidrug-Resistant Cancer Cells by Antagonizing ABCG2-Mediated Drug Transport. Pharmaceuticals (Basel, Switzerland) 16 (11) (2023)
Chao-Yun Cai, Qiu-Xu Teng, Megumi Murakami, Suresh V Ambudkar, Zhe-Sheng Chen, Vijaya L Korlipara
Design, Synthesis and Biological Evaluation of Quinazolinamine Derivatives as Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors with Improved Metabolic Stability. Biomolecules 13 (2) (2023)
Andaleeb Sajid, Sabrina Lusvarghi, Megumi Murakami, Eduardo E Chufan, Biebele Abel, Michael M Gottesman, Stewart R Durell, Suresh V Ambudkar
Reversing the direction of drug transport mediated by the human multidrug transporter P-glycoprotein. Proceedings of the National Academy of Sciences of the United States of America 117 (47) (2020)